Dimethylcarbate

Dimethylcarbate

SCHEMBL149385

CN(C)C(=O)[O-].CN(C)C(=O)[O-].CN(C)C(=O)[O-].[Nd+3]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
TSHR P16473 2/20 0.44
CA1 P00915 4/20 0.43
HSD17B10 Q99714 3/20 0.39
MAPT P10636 2/20 0.39
NFKB1 P19838 1/20 0.39
THPO P40225 1/20 0.39
APEX1 P27695 1/20 0.39
PMP22 Q01453 1/20 0.39
CA4 P22748 3/20 0.38
TAS2R38 P59533 1/20 0.38
CA12 O43570 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
TP53 P04637 2/20 0.33
HPGD P15428 2/20 0.33
ALOX15 P16050 2/20 0.33
ALOX12 P18054 2/20 0.33
MAPK1 P28482 2/20 0.33
TDP1 Q9NUW8 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylcarbate SCHEMBL28489364 0.92 ALDH1A1 (0.44) ALDH1A1TSHRCA1HSD17B10MAPT
Dimethylcarbate SCHEMBL672821 0.92 ALDH1A1 (0.44) ALDH1A1TSHRCA1HSD17B10MAPT
Dimethylcarbate SCHEMBL28491926 0.92 ALDH1A1 (0.44) ALDH1A1TSHRCA1HSD17B10MAPT
Dimethylcarbate SCHEMBL6868659 0.92 ALDH1A1 (0.44) ALDH1A1TSHRCA1HSD17B10MAPT
Dimethylcarbate SCHEMBL672819 0.92 ALDH1A1 (0.44) ALDH1A1TSHRCA1HSD17B10MAPT
Dimethylcarbate SCHEMBL673767 0.92 ALDH1A1 (0.44) ALDH1A1TSHRCA1HSD17B10MAPT
Dimethylcarbate SCHEMBL673574 0.92 ALDH1A1 (0.44) ALDH1A1TSHRCA1HSD17B10MAPT
Dimethylcarbate SCHEMBL639148 0.92 ALDH1A1 (0.44) ALDH1A1TSHRCA1HSD17B10MAPT
Dimethylcarbate SCHEMBL1873905 0.92 ALDH1A1 (0.44) ALDH1A1TSHRCA1HSD17B10MAPT
Dimethylcarbate SCHEMBL3272509 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 414 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3969490-B1 MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND TIRE COMPONENTS BRIDGESTONE CORP (JP) 2026-03-25 EP disclosed
US-12565546-B2 Imine group-containing novel compound, modified conjugated diene-based polymer including same, method for preparing the polymer, and rubber composition including the polymer LG CHEM, LTD. (KR) 2026-03-03 US disclosed
US-20250389555-A1 MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) 2025-12-25 US disclosed
US-12410263-B2 Modified high-Cis polybutadiene polymer, related methods and rubber compositions BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) 2025-09-09 US disclosed
EP-4032921-B1 METHOD FOR PREPARING MODIFIED CONJUGATED DIENE-BASED POLYMER LG CHEMICAL LTD (KR) 2025-08-27 EP disclosed
US-12371516-B2 Aged lanthanide-based catalyst systems and their use in the preparation of cis-1,4-polydienes BRIDGESTONE CORPORATION (JP) 2025-07-29 US disclosed
US-12264232-B2 Modified high-cis polybutadiene polymer, related methods and tire components BRIDGESTONE CORPORATION (JP) 2025-04-01 US disclosed
US-20250066516-A1 HYDROGENATED POLYBUTADIENE POLYMERS AND RUBBER COMPOSITIONS INCORPORATING SAME BRIDGESTONE CORPORATION (JP) 2025-02-27 US disclosed
US-12209149-B2 Continuous preparation system of conjugated diene-based polymer LG CHEM, LTD. (KR) 2025-01-28 US disclosed
EP-4495146-A2 MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS Bridgestone Americas Tire Operations, LLC (US) 2025-01-22 EP disclosed
US-7008899-B2 Lanthanide-based catalyst composition for producing cis-1,4-polydienes BRIDGESTONE CORPORATION (JP) 2006-03-07 US disclosed
WO-2005061563-A1 BULK POLYMERIZATION PROCESS FOR PRODUCING POLYDIENES BRIDGESTONE CORPORATION (JP) 2005-07-07 WO disclosed
US-20050131174-A1 Bulk polymerization process for producing polydienes BRIDGESTONE CORP. 2005-06-16 US disclosed
US-6897270-B2 Continuous process for the production of conjugated diene polymers having narrow molecular weight distribution and products therefrom BRIDGESTONE CORPORATION (JP) 2005-05-24 US disclosed
US-20050038215-A1 Lanthanide-based catalyst composition for producing cis-1,4-polydienes BRIDGESTONE CORPORATION (JP) 2005-02-17 US disclosed
US-20040116638-A1 Continuous process for the production of conjugated diene polymers having narrow molecular weight distribution and products therefrom BRIDGESTONE CORPORATION (JP) 2004-06-17 US disclosed
US-6699813-B2 COMPOSITION THAT IS COMBINATION OF OR REACTION PRODUCT OF LANTHANIDE COMPOUND, ALKYLATING AGENT, NICKEL-CONTAINING COMPOUND, AND OPTIONALLY HALOGEN-CONTAINING COMPOUND THAT INCLUDES ONE OR MORE LABILE HALOGEN ATOMS BRIDGESTONE CORPORATION (JP) 2004-03-02 US disclosed
EP-1370593-A1 CONTINUOUS PROCESS FOR THE PRODUCTION OF CONJUGATED DIENE POLYMERS HAVING NARROW MOLECULAR WEIGHT DISTRIBUTION AND PRODUCTS THEREFROM Bridgestone Corporation (JP) 2003-12-17 EP disclosed
US-20030176276-A1 Lanthanide-based catalyst composition for the manufacture of polydienes BRIDGESTONE CORPORATION (JP) 2003-09-18 US disclosed
WO-2002068484-A1 CONTINUOUS PROCESS FOR THE PRODUCTION OF CONJUGATED DIENE POLYMERS HAVING NARROW MOLECULAR WEIGHT DISTRIBUTION AND PRODUCTS THEREFROM BRIDGESTONE CORPORATION (JP) 2002-09-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12565546-B2 Imine group-containing novel compound, modified conjugated diene-based polymer including same, method for preparing the polymer, and rubber composition including the polymer CARM1, RIF1, UFM1 ALDH1A1 832/4885TSHR 2424/4885CA1 4752/4885
US-20250389555-A1 MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS MALT1, INO80C, RTCB ALDH1A1 778/4885TSHR 1694/4885CA1 678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.